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the cellular abundance of transcription factors (tFs) is an important determinant of their regulatory activities. deriving tF copy numbers is therefore crucial to understanding how these proteins control gene expression. We describe a sensitive selected reaction monitoring-based mass spectrometry assay that allowed us to determine the copy numbers of up to ten proteins simultaneously. We applied this approach to profile the absolute levels of key tFs, including PPArg and rXra, during terminal differentiation of mouse 3t3-l1 preadipocytes. our analyses revealed that individual tF abundance differs dramatically (from ~250 to >300,000 copies per nucleus) and that their dynamic range during differentiation can vary up to fivefold. We also formulated a dnA binding model for PPArg based on tF copy number, binding energetics and local chromatin state. this model explains the increase in PPArg binding sites during the final differentiation stage that occurs despite a concurrent saturation in PPArg copy number.
Differential gene expression is controlled by gene regulatory networks, which consist of functional interactions between regulatory state components (such as TFs) and genomic components (such as gene promoters and enhancers) 1 . A major current interest is to derive models of gene regulatory networks that elucidate or predict the dynamic transcriptional mechanisms underlying complex gene expression programs [2] [3] [4] . An important drawback of existing models is that relatively little quantitative information has so far been used in their calibration. In particular, accurate measurements of the absolute molecular abundance of most TFs are still sparse 2 even though such information is key for understanding most biochemical and regulatory processes involving this type of protein 5, 6 . This conundrum can be explained by the relatively low expression of TFs in cells 7 , which makes their direct quantification or that of any other low abundant protein by mass spectrometry or other assays a substantial challenge.
Newly emerging proteomic approaches combining selected reaction monitoring (SRM) or high-resolution mass spectrometry with isotope-dilution quantification strategies can alleviate the scarcity of copy-number data as they enable quantitative analyses over a wide concentration range [8] [9] [10] . These approaches share the same principle of targeting a subset of detectable peptides, which are specific to the protein of interest (proteotypic peptides) 11 . Quantification is achieved by comparing the mass spectrometry signals of the extracted peptides to those of accurately quantified, isotope-labeled peptides, which are used as internal standards 8 . Isotope-labeled peptides can be produced synthetically 8 or are now increasingly being derived from the proteolysis of full-length proteins that are themselves recombinantly [12] [13] [14] [15] [16] expressed or synthetically derived 17 . The use of isotope-labeled full-length proteins offers clear advantages over other recently developed quantification approaches (Supplementary Table 1 ). Both synthetic-and recombinant-based approaches can introduce single reference [16] [17] [18] [19] or solubility (for example, albuminbinding protein 15 or glutathione S-transferase 14 ) tags linked to parent proteins. This enables the stoichiometric quantification of peptide standards released upon protein digestion, and these standards are then used to quantify the endogenous protein in a complex sample.
However, despite the potential of such targeted mass spectrometry approaches for deriving accurate protein copy-number measurements, particularly for low-abundance proteins, only a few studies incorporating these methods have so far demonstrated their capacity to accurately measure copy numbers of TFs in higher eukaryotes 14, 15 . In addition, none of these studies was, to our knowledge, specifically optimized to tackle the difficult task of monitoring the dynamic expression of TFs over the course of specific biological processes. Furthermore, currently available approaches typically rely on the use of a single reference peptide or tag that is spiked early in the analytical process. Although such a reference tag corrects for the concomitant loss in endogenous peptides during sample digestion and fractionation and thus increases accuracy and reproducibility 20, 21 , the use of only one reference tag requires that the quantification of each protein standard be accomplished separately. This ultimately adds avoidable steps into the workflow, potentially introducing undesirable artifacts (Supplementary Table 1) .
These collective considerations prompted us to develop an SRM-based workflow, specifically tailored around the quantification of low-abundance proteins such as TFs, in which the internal proteinstandard quantification step is performed entirely in situ (that is, the protein standard and its endogenous counterpart are simultaneously quantified). We applied this workflow to assess the dynamic changes in absolute TF levels during the terminal phase of adipogenesis. Although quantitative proteomic studies have been performed to explore the adipogenic proteome, these lacked the required sensitivity to detect and quantify even core adipogenic master regulators such as PPARγ and RXRα 22, 23 , illustrating the inherent complexity of targeting TFs 23 . results selection of tF-specific transitions for targeted srm The selection of proteotypic peptides for TFs proved challenging, mainly because of the scarcity of TF data in public repositories and the difficulty of detecting TF-specific tryptic peptides in discovery experiments (Supplementary Fig. 1 and Online Methods).
We therefore decided to adopt an in vitro full-length protein expression-based strategy to derive proteotypic peptides, which allows for a better accounting of the local environment surrounding the peptide cleavage sites (Online Methods and data not shown). After selecting ten TFs (including PPARγ and RXRα) that are expressed during terminal adipogenesis, we tagged the corresponding recombinant proteins with C-terminal glutathione S-transferase for full-length expression validation and purification (Supplementary Table 2 and Supplementary  Fig. 2 ). In-gel separation followed by high-resolution liquid chromatography-tandem mass spectrometry (LC-MS/MS) of the tagged TF-containing fraction enabled us to generate a collection of experimentally detected TF-specific tryptic peptides for the ten proteins (Supplementary Data 1 and Online Methods). 18, 19, 25 into the gel-based workflow described above for transition selection. This strategy relies on the simplification of full-length protein quantification using reporter peptide tags 18, 19 and on the increased detection sensitivity provided by SRM-based mass spectrometry measurements. For this purpose, we aimed to add an in-frame proteotypic referencepeptide tag at the N terminus of the protein constructs that should serve as surrogate during the quantification step. After having considered several possibilities 18, 19 (Online Methods), we found that the SH-quant peptide 19 offers optimal solubility and stability properties (Supplementary Fig. 3 ). We therefore adopted it for the in situ quantification of heavy TFs using a synthetic and accurately quantified light SH-quant counterpart. In this manner, only one peptide (the SH-quant) is used for the absolute quantification of a heavy, in vitro-expressed standard TF, thus simplifying and reducing the cost of the assays even further. In turn, absolute quantification of the endogenous TF is achieved by using TF-specific peptides (Fig. 1a,b) .
Absolute quantification of PPArg and rXra
To evaluate PPARγ and RXRα peptide transitions, we implemented two separate pilot SRM analyses as depicted in Figure 1a and exemplified in Figure 1b ,c (details in Supplementary  Figs. 4-6) . Subsequently, the complete workflow was applied to monitor the absolute nuclear abundance of PPARγ and RXRα during terminal adipogenesis. The technical robustness of the whole workflow is highlighted by the low coefficient of variation obtained with one biological sample (Supplementary Fig. 7 ). The resulting data ( Fig. 2 and Supplementary Table 3 ) demonstrate the dynamic nature of the protein copy number per cell (nucleus) profiles of PPARγ and RXRα during terminal adipogenesis. To corroborate our results and to provide an independent assessment of the accuracy of our method, we performed three validation experiments. First, we performed western blot analysis for each time point (Supplementary Fig. 8 and Online Methods), revealing that the detected TF abundance profiles mirror those from our SRM-based quantification approach. We also performed semiquantitative western blotting on RXRα. Given the unavailability of purified mouse RXRα, we generated a calibration curve using SRM for the quantification of in vitro-expressed RXRα standard and used it for western blotting-based quantification of endogenous RXRα at different time points during terminal adipogenesis ( Supplementary Fig. 9a,b and Online Methods). The resulting data show a good correlation with the SRM-based measurements ( Supplementary Fig. 9c,d ; R 2 = 0.72), although we found that the western analysis tends to inflate RXRα copy numbers as compared to SRM-derived data.
To resolve this finding, and because this experiment was not truly independent, we performed a second validation assay. Using the workflow presented in Figure 1a , we randomly selected and accurately quantified two human proteins of different molecular weight, α-synuclein (SYN, 14.5 kDa) and histidyl-tRNA synthetase (HARS, 57.4 kDa), to assess overall protein recovery. The HARS protein was selected because it falls within the molecular weight range of our TFs of interest, whereas SYN was selected to test the recovery of a significantly smaller protein. Each protein was spiked in amounts corresponding to 5,000 and 50,000 copies per cell in nuclear extracts to mimic the concentration range observed for TFs as well as the experimental nucleic background proteome (Online Methods). Our SRM validation predicted 4,620 and 45,950 copies of HARS per cell, corresponding to an overall protein recovery of ~92% for both (Supplementary Figs. 10a-e  and 11 ). Slightly lower numbers were obtained for SYN, showing a recovery ranging from 65% to 80% (Supplementary Figs. 10f  and 11 ). This lower performance may have been caused by several factors, but we suspect that its small size may have led to greater diffusion during the gel de-and rehydration processes applied before digestion, resulting in greater protein loss.
Finally, to assess the impact of gel fractionation on the accuracy of our method, we performed a gel recovery experiment using RXRα as a reference protein (Online Methods). We found that losses associated with sample processing were ~30% for small protein amounts (<2.5 ng), whereas this improved to ~8% for larger amounts (Supplementary Fig. 12 ). We thought it reasonable to conclude that absolute values obtained for the targeted TFs at different differentiation times should lie within the same error margin.
Together, these experiments provide a candid assessment of the precision of the presented SRM-based quantification approach, revealing a high accuracy for protein quantities above 2.5 ng based on the HARS and RXRα measurements. These values are in line with those reported in recent studies (for example, in ref. 15 npg are thus consistent with what is considered an acceptable measurement inexactitude in the field. In addition, these experiments demonstrate that our pipeline is in principle applicable to any protein as long as it expresses well in vitro.
A quantitative model of genome-wide tF dnA binding
The availability of absolute protein copy-number data allowed us to examine the relationship between the number of genome-wide DNA binding events and TF molecules. Using published RXRα and PPARγ ChIP-seq data 26 , we found that, until the fourth differentiation day, the number of TF molecules and corresponding binding events correlated well (R 2 = 0.96 for PPARγ; R 2 = 0.85 for RXRα; Supplementary Fig. 13 ) and that, in general, there were substantially more RXRα than PPARγ binding events, consistent with their corresponding TF copy numbers. These high correlations indicate that ChIP-seq occupancy data likely reflect endogenous conditions rather than differences in antibodymediated protein recoveries as previously hypothesized 26 . A striking discrepancy, however, was observed on day 6, when the number of RXRα and PPARγ binding events substantially increased (to more than threefold for both TFs), whereas the number of TF molecules saturated or even decreased ( Supplementary Fig. 13 ).
To reconcile these findings, we generated a quantitative model to predict the number of PPARγ binding events in the genome given a number of TF molecules, a ChIP detection threshold and genome accessibility maps (Supplementary Note). This model bears similarity to previous thermodynamic models of protein-DNA interactions 3,27,28 but also features some important differences: notably, the use of absolute TF levels instead of inferred protein concentration data and the focus on modeling DNA binding behavior over the course of a mammalian cellular differentiation process. To incorporate genome accessibility data into our model, we used published genome-wide data of the chromatin mark histone 3 lysine 27 monoacetylation (H3K27ac) for differentiation days 0, 2 and 6 (ref. 29) , as this mark is enriched at active, and thus accessible, genomic regions. Consequently, we formulated the model to account for the distribution of specific and nonspecific sites for PPARγ in H3K27ac-enriched regions (Fig. 3a) . To assess the DNA binding events at thermodynamic equilibrium, we assumed that all the PPARγ proteins were on the DNA at either specific or nonspecific sites, consistent with the consensus in the field that TFs tend to reside mostly on DNA in vivo 6 . For the sake of simplicity, we did not consider interactions with other TFs or hindrance due to other proteins sitting on DNA (Supplementary Note).
The resulting model predicts the number of binding events given the number of PPARγ copies per cell (nucleus) for each time point as a function of the ChIP detection threshold expressed as percent occupancy (or residency time) (Fig. 3b) . Although it is difficult to precisely estimate the latter threshold, a survey of our own and published ChIP data revealed that the signal associated with DNA binding is typically considered as positive from around 1% (as compared to input) 30, 31 . Notably, when we used 1.35% as the detection threshold, our model predicted binding-event numbers that closely mimic the experimentally derived data (Fig. 3c) . Thus, the model correctly predicts the temporal pattern in the number of binding sites over the course of terminal adipogenesis.
As an independent test, we also repeated our analyses using another PPARγ ChIP-seq data set 32 , which yielded similar conclusions (Supplementary Note). A closer look into the determining factors revealed that the sharp increase in binding events at day 6 as compared to days 0 and 2 is in part driven by the increase in PPARγ copy number between days 2 and 6. However, we found that an equally important factor relates to shifts in the relative distributions of higher-versus lower-affinity sites in accessible genomic regions at the different differentiation time points (Fig. 3a) . Specifically, whereas the overall size of accessible regions is similar across all days, we found that cells undergo more substantial chromatin remodeling between days 2 and 6 than between days 0 and 2 such that more medium-to-high affinity sites for PPARγ become available. This in turn allows for a substantial increase in detectable DNA binding events even though the TF copy number increase is relatively modest. Together, these analyses show the value of accurately quantifying TF copy numbers to generate quantitative DNA binding models from which emergent properties regarding gene regulatory mechanisms underlying a specific biological process can be derived.
multiplexing the srm pipeline Next we sought to overcome the current quantification limit of only one protein per assay. For this purpose, we designed nine quantotypic SH-quant tag variants that, along with the original SH-quant tag, allow the quantification of up to ten proteins or TFs in a single integrated SRM analysis. We subsequently generated ten expression vectors enabling the coupling of each tag variant to a distinct adipogenic TF (among which we also included PPARγ and RXRα for validation). The corresponding transitions and retention time of the parent ions are presented in Figure 4a . The performance and chromatographic separation of the nine newly designed candidates and their parent SH-quant sequence . The x axis runs from the strongest-affinity (that is, 1,000-fold stronger than nonspecific sites) to mediumaffinity (that is, 60-fold stronger) sites.
(b) Number of detected bound loci at D0 (gray), D2 (dashed) and D6 (black) during 3T3-L1 terminal differentiation as a function of the detection threshold on the expected occupancy. The model takes into account the measured PPARγ copies per cell (nucleus) and the distribution of accessible high-affinity sites. (c) Temporal pattern for the predicted number of detected PPARγ-bound sites (dashed), actual number of measured sites (black) and protein copy number (gray). The number of sites shows an exponential-like increase, whereas the protein copy-number graph reflects saturation.
npg and ARID3a fell below the quantification threshold. Nevertheless, the overall quality of the fragment ions monitored for the heavy and light peptides (Supplementary Fig. 18 ) allowed for the unambiguous identification of these TFs.
discussion
Determining the copy number of TFs has been of longstanding interest given that the DNA-binding ability of a TF, and hence its regulatory capacity, strongly depends on its cellular concentration 5, 6 . However, despite the fundamental importance of TFs in most biological processes, a recent survey showed that the number of studies that have so far provided estimates of the abundance of animal TFs is low (~25) 6 . Moreover, these estimates were achieved mostly with indirect immuno-based measuring methods whose major drawback is the dependence on antibodies that are available for only a few TFs. Nevertheless, these studies estimated TFs to be expressed in the range of 5,000 to several hundred thousand copies per nucleus 6 , in line with our results. We believe our SRM-based workflow, which affords sufficient sensitivity and analytic reproducibility to generate absolute quantitative data, even for low-abundance proteins, will circumvent the issues typically encountered with immuno-based methods were tested in a series of SRM runs (Fig. 4) . Two SH-quant tag variants, AADITSLYK and AAEVTSLYK, were isobaric and yet could be clearly distinguished by their chromatographic profile and their distinct transitions (Fig. 4b-e) . We established a standard curve for each SH-quant tag variant by spiking them into the same 3T3-L1 nuclear extract preparation that was next used for TF abundance measurements (Supplementary Figs. 14 and 15) . This allowed us to determine the lower limit of quantification for each tag (Supplementary Fig. 16 ).
Applying this multiplex version of our methodology, we were able to monitor endogenous levels of ten TFs (Supplementary Table 2 ) in 3T3-L1 nuclear extracts derived from three terminal differentiation time points (day 0, day 2 and day 4) (Fig. 5a,b) . As summarized in Figure 5c and Supplementary Figure 17 , we found that the majority of the additionally analyzed TFs (for example, PIAS4, NFIB, SMAD2, RARγ and FOSL2) were expressed within approximately the same copy-number range as PPARγ or RXRα (Supplementary Table 3) . Notably, measurements of PPARγ and RXRα copy numbers were consistent with data obtained with the nonmultiplex approach, indicating that the scaling up of the SRM assay did not interfere with measurement precision. The abundance of other TFs such as PIAS3, NR2C1 npg that additional quantotypic tags are designed and validated such that accuracy and sensitivity are maintained. We believe that our quantification strategy constitutes a powerful alternative to quantitative immunoassays (immunoblotting or ELISA) for determining fluctuations in protein abundance over a wide concentration range, with the additional advantages of being able to multiplex and being independent of protein-specific antibodies 35 . This multiplex capacity should be of great value for examining or modeling absolute, dynamic changes of entire pathways or sets of biomarkers of interest in wild-type versus clinical, disease or perturbation settings.
Here we illustrate the importance of deriving this type of data by building a quantitative model aiming to clarify an intriguing discrepancy between TF binding site and copy-number data. As such, we provide a quantitative explanation for the common observation that many TFs, including PPARγ, bind to significantly fewer sites in the genome than predicted based on the presence of their respective consensus motifs 29, 36, 37 . Whereas it has previously been suggested that other factors may contribute to this binding-site selectivity, here we demonstrate that, at least for PPARγ, the TF DNA-binding profile can be closely modeled by simply considering its own copy number, simple thermodynamic principles and chromatin accessibility. The functional consequence of our findings is that the chromatin state constitutes a landing map for PPARγ DNA binding, consistent with the emerging notion that chromatin structure is important in shaping TF DNA-binding patterns 37 .
methods
Methods and any associated references are available in the online version of the paper. and therefore increase our understanding of protein function and behavior. This in turn should be of great value for probing and modeling different types of biological processes, from membrane signaling over signal transduction to gene regulation, as the functional outcome of these processes is often directly linked to the abundance of implicated proteins.
This workflow offers several advantages. First, the only requisite of our SRM-based approach is the relatively straightforward in vitro expression of the protein candidate, which, except for certain types of proteins, is fairly trivial given the availability of efficient cloning and expression systems and open reading frame (ORF) clone libraries 33, 34 . Easy access to the full-length protein facilitates the empirical selection of the best quantotypic peptides for protein types that may not be well represented in spectral library databases (such as TFs). In addition, the ability to nearly extemporaneously produce heavy-labeled full-length protein standards and to simultaneously quantify these protein standards and their endogenous counterparts in the same assay bypasses another significant source of variability in any quantitative assay, namely the necessity for protein and peptide storage 24 .
Second, our workflow uses the quantotypic SH-quant reporter peptide, which was found to feature high digestibility, excellent solubility, ionizability and stability and thus to exhibit optimal peptide properties for the robust and accurate quantification of proteins. The SH-quant tag allowed the design of tag variants with very similar properties, enabling the in situ analysis of multiple proteins in a single analysis in a robust, sensitive and reproducible fashion. In this work, we deliberately limited the number of TFs that were simultaneously quantified in situ. This is because we found that further multiplexing could jeopardize the overall sensitivity of the approach, as it was specifically conceived to accommodate the measurement of ten TFs at the time. However, our approach is in principle not limited to ten target proteins, provided npg online methods 3T3-L1 cell culture, differentiation and protein extraction. 3T3-L1 cells were cultured and differentiated into adipocytes as detailed in Raghav et al. 31 . Briefly, 3T3-L1 cells were collected at six different differentiation time points (0 h, 2 h, day 1, day 2, day 4 and day 6). At each time point, Petri dishes were rinsed twice with 1× PBS, after which cells were trypsinized, rinsed once with cold 1× PBS and centrifuged, and the pellets were then stored at −80 °C. Cells were lysed in cold lysis buffer (10 mM HEPES-NaOH at pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 1 mM DTT, 0.5% NP-40, 0.1 mM EDTA, 0.1 mM EGTA) containing protease inhibitors and phosphates inhibitors (Roche) for 15 min and centrifuged for 10 min at 6,000 r.p.m. (at 4 °C) to sediment the nuclei. The pellet was washed twice to remove non-nuclear particles. The isolated nuclei were then washed using protein extraction buffer (20 mM HEPESNaOH at pH 7.9, 25% glycerol, 1.5 mM MgCl 2 , 420 mM NaCl, 0.1 mM EDTA, 0.1 mM EGTA), after addition of protease inhibitor and phosphatase inhibitor cocktail tablets (Roche), at 4 °C for 30 min and centrifuged for 10 min at 6,000 r.p.m. (at 4 °C). Protein concentration was measured for each time point using the Quick Start Bradford Dye Reagent (Bio-Rad). The supernatant containing nuclear proteins was collected and stored at −80 °C.
Cloning and plasmids.
Mouse TF ORFs were cloned in Gateway format essentially as described earlier 31, 34 . To make the wheat germ (WG) in vitro transcription-translation expression system (Promega) compatible with the mouse TF ORF clones and to allow the purification of TFs, we modified the SP6 pF3A WG (BYDV) Flexi vector (Promega) to accommodate the Gateway reading frame A cassette (Invitrogen). A glutathione S-transferase (GST) coding sequence containing a stop codon was subsequently incorporated in-frame at the 3′ end of the second (i.e., 3′) Gateway site using standard cloning techniques. TFs were then subcloned from the Gateway entry clone level into this in-house-modified pF3A-GST destination vector by standard Gateway cloning.
In vitro protein expression and purification, gel staining and immunoblotting. For selection of optimal TF transitions: the ten selected TFs containing a GST tag at their C termini were expressed in vitro via the TnT SP6 High-Yield Wheat Germ Protein Expression System (Promega) according to the manufacturer's protocol. GST-labeled TFs were subsequently purified via glutathione Sepharose 4B beads (GE Healthcare) and incubated overnight at 4 °C on a rotator to enrich for the GST-fusion proteins. The beads were washed three times with a saline buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 2mM EDTA, 0.1% NP-40, 10% glycerol) and boiled at 95 °C for 5 min in protein loading buffer to release the fusion proteins. The protein-bead mixture was centrifuged at 6,000 r.p.m. for 30 s to sediment the beads. The supernatant fraction was separated by SDS-PAGE in a 10% resolving gel (Tris-glycine) and stained either with silver nitrate or with Coomassie blue (SimplyBlue Safestain, Invitrogen) for band visualization. Validation of in vitro-expressed proteins was performed by western blotting using 1:2,000 diluted rabbit anti-GST primary antibodies (Cell Signaling, 2622S) and 1:5,000 diluted goat anti-rabbit coupled to HRP secondary antibodies (Santa Cruz, SC-2004) on a nitrocellulose membrane. Validation of PPARγ and RXRα expression was performed again by western blotting using 1:500 diluted rabbit anti-PPARγ (Santa Cruz, SC-7196) and 1:1,000 diluted rabbit anti-RXRα (Santa Cruz, SC-553) primary antibodies and using 1:1,000 diluted PARP-1 as a nuclear control (Santa Cruz, SC-1561). Densitometric quantitation analyses were performed using the AlphaDigiDoc 1201 software (Alpha Innotech). (Semi)-quantitative western blotting: for RXRα standard curve generation, in vitro-expressed RXRα was purified as described above. An aliquot was subjected to SRM for quantification (see below), which aided in the generation of an RXRα dilution series (0.31-20 ng). The corresponding RXRα standard-curve samples and 3T3-L1 nuclear extracts harvested at different time points during differentiation were then subjected to western blotting as described above.
For TF quantification: the ten selected TFs were expressed in vitro via the TnT SP6 Wheat Germ High-Yield Master Mix Minus Amino Acids (Promega) in their isotopically labeled versions. Eighteen amino acids were mixed to reach a 80 µM final concentration and added to the reaction together with isotopically labeled arginine ([ 13 C, 15 N]Arg) and lysine ([ 13 C, 15 N]Lys) (Cambridge Isotope Laboratories) to a 1 mM final concentration before we resorted to the conventional expression protocol. Depending on the TF analyzed, 3× reactions were used (or 4× for TFs with low expression yields). Subsequently, the purification and fractionation techniques described above were applied.
Assessment of protein losses during gel extraction. RXRα was
in vitro expressed and purified with glutathione Sepharose 4B beads as described before. A series of dilutions (10 ng to 1.25 ng) was generated. One dilution set was used for validation by western blotting using 1:1,000 diluted rabbit anti-RXRα (Santa Cruz, SC-553) as described above. The second dilution set was loaded onto a 10% SDS-PAGE, stained with Coomassie blue, after which bands corresponding to RXRα were excised and in-gel digested (as described earlier). To assess protein losses during in-gel digestion, the resulting RXRα samples were further quantified by SRM.
Reference peptide tag incorporation. SH-quant quantification strategy. The SH-quant peptide (AADITSLYK) coding sequence along with the segment of the 5′ Gateway site between the PvuI and PvuII restriction sites was synthesized by Geneart-Life Technologies. An SpeI restriction site was added at the 3′ end of the tag coding sequence to simplify the insertion of tag variants. The SH-quant insert was introduced in the PvuI and PvuII restriction sites at the 5′ Gateway site of the pF3A-GST vector by double digestion with the two restriction enzymes and subsequently ligated to obtain the SH-pF3A-GST destination vector.
FLEXIQuant quantification strategy. The same cloning strategy as explained above was applied; here the SH-quant peptide coding sequence was replaced by a FLEXIQuant (TENLYFQGDISR) coding sequence directly linked to a Strep-tag sequence (WSHPQFEK) at its 3′ end to ultimately obtain a Flex-pF3A-GST destination vector.
Reference peptide tag variant design for multiplexing. The additional tags 2-5 displayed in Figure 4 were designed by a first permutation of isoleucine residue 4 from the original SH-quant tag sequence with amino acids of different hydrophobicity and size (Gly, Ala, Val and Phe) to introduce molecular weight and/or retention time differences without altering the fragmentation pattern. Additional tags 6-10 were generated by a npg second permutation conservative of the charge by replacing aspartic acid residue 3 by glutamic acid in the five sequences generated as above. Hydrophilic residues threonine 5 and tyrosine 8, which produce intense y-fragment ions, were kept constant to maintain solubility and sensitivity. The in vitro expression vector SH-pF3A-GST was modified via site-directed mutagenesis (QuikChange Lightning, Stratagene) according to the manufacturer's protocol to generate the SH-quant peptide variant-incorporating vectors (SH i -pF3A-GST). The I4G, I4A, I4V, I4F, D3E, D3E-I4G, D3E-I4A, D3E-I4V and D3E-I4F substitutions were introduced into SH-pF3A-GST using the forward and reverse primers presented in Supplementary Table 4 and sequence verified. Proteotypicity of the newly designed tags was confirmed with BLAST-P against the mouse protein database (http://blast.ncbi.nlm.nih.gov/).
In vitro-expressed TF identification. In vitro-expressed proteins were in-gel digested using trypsin as follows: the samples were reduced in 10 mM dithioerythritol (DTE) and alkylated in 55 mM iodoacetamide (IAA) before being dried. The samples were then incubated with 12.5 µg/ml of trypsin (in 50 mM ammonium bicarbonate, pH 7.5) overnight at 37 °C. The resulting tryptic peptides were extracted from the gel slices, dried and resuspended in 2% acetonitrile (ACN):0.1% formic acid (FA) for LC-MS/MS analysis. A mass spectrometer (LTQ Orbitrap XL; Thermo Fisher Scientific) equipped with an ultraperformance LC (UPLC) system (nanoACQUITY; Waters) was used. Peptides were trapped in a custom-made precolumn (Magic C18 AQ stationary phase, 5-µm diameter, 200-Å pore, 0.1 mm × 20 mm, Michrom Bioresources) and separated in a custom-made main column (Magic C18 AQ, 3 µm-diameter, 100-Å pore, 0.75 mm × 150 mm), using a run of 53 min and a gradient of H 2 O:ACN:FA 98%:2%:0.1% (solvent A) and ACN:H 2 O:FA 98%:1.9%:0.1% (solvent B). The gradient of the run was set at a flow rate of 250 nl/min as follows: 100% A for 3 min, 30% B within 36 min, 47% B within 14 min, 90% B within 5 min, held for 5 min and 100% A for 17 min. The MS/MS was operated in an information-dependent mode, in which each full MS analysis was followed by ten MS/MS acquisitions during which the most abundant peptides were selected for collision-induced dissociation (CID) to generate tandem mass spectra. The normalized collision energies were set to 35% for CID. Data search was performed using Mascot software (v.2.3; Matrix Science) and Proteome Discoverer (v.1.3; Thermo Fisher Scientific). The sequences were searched against a concatenated database consisting of a Triticum aestivum (wheat) database created from UniProt database v.12.02 (4,684 sequences) and the sequences of the TF constructs expressed complemented with a set of common contaminant proteins sequences. Finally, the results were imported into Scaffold (v.3.3; Proteome Software) for validation of protein identification, normalization and comparison of spectral counts. Peptide identifications were accepted if they could be established at a probability of >95% as determined by the PeptideProphet algorithm 38 . Protein identifications were accepted if they were assigned at least two unique validated peptides and could be established with at least 99% probability as determined by the ProteinProphet algorithm 39 .
Proteotypic peptide selection. We initially turned to fragmentation spectra databases such as the NIST (http://www.nist.gov/nvl/) and PeptideAtlas 40 to select the ideal pool of peptide candidates for the design of our SRM-based assay, aiming to monitor nuclear PPARγ and RXRα abundance during terminal adipogenesis. However, only a limited amount of information regarding TFspecific peptides could be retrieved. We therefore had to devise a strategy that did not rely on the use of publicly available information to discover proteotypic peptides of TFs. To alleviate concerns regarding the detectability of TFs, we implemented three different bidimensional peptide fractionation pipelines on 3T3-L1 total nuclear protein extracts at day 4 of differentiation (a time point at which the adipogenic master regulators PPARγ and RXRα are known to be highly expressed 31, 41 ) with the precise aim of discovering TF-specific peptide candidates that could be used in downstream quantitative analyses. However, only two peptides for each TF were retrieved in spite of the higher resolving power provided by the extensive fractionation and the consecutive higher sensitivity expected in mass spectrometry (Supplementary Fig. 1) . Thus, despite recent increases in overall sensitivity 42 , MS-based shotgun data-dependent methodologies are still lacking the combination of acquisition speed and sensitivity necessary to directly analyze low-abundance proteins such as TFs within complex matrices derived from mammalian cells. The results of these preliminary experiments may also in part explain the scarcity of TF-specific peptides that we initially observed in databases. In response, we and others 14 are currently undertaking significant efforts to address this TF data paucity, but it is clear that current TF-specific peptide repositories are still far from complete. An alternative strategy based on the combined use of proteotypic peptide prediction tools 43 and crude peptides synthesis 44 also did not improve the quality of our acquired data. In fact, a great majority of the 51 crude synthetic peptides selected were either hardly or not consistently detectable over the time course of the experiment (data not shown). We attribute this behavior to peptide solubility, stability and ionizability issues, and we decided, therefore, not to continue with this strategy. However, we followed the steps indicated below to select the representative proteotypic peptides.
Peptide proteotypicity. Candidate proteotypic peptides were selected using Pinpoint (v.1.1; Thermo Fischer Scientific), and their fragmentation spectra were visually checked in Skyline 45 using the spectral library inspection function. The following rules were applied in Pinpoint and Skyline to the tryptic peptides detected to ensure that only high-quality peptides were retained for the analysis.
1. Peptide uniqueness. As a general rule, the TF-specific peptides selected here were uniquely representative of the TF of interest. In some instances, however, empirically observed best-flying candidates were shared among two or more TF isoforms or TF subfamily members and were included in the assay. Discarding such candidates for less-than-optimal ones could compromise detectability. Therefore, the precision of absolute measurements accomplished using such nonunique TF-specific peptides may be affected to a certain extent by TF isoform(s) or subfamily counterpart(s). The following nonunique peptides were used in the multiplexed assay. ARID3a: peptide GLNLPTSITSAAFTLR is shared with ARID3b; NFIB: peptide EDFVLTVTGK is shared with NFIA, and GIPLESTDGER is shared with NFIA and NFIC; PIAS3: peptide VSELQVLLGFARG is shared with PIAS2; RXRα: peptide VLTELVSK is shared with RXRβ, and ILEAELAVEPK is shared with RXRγ; SMAD2: peptide VETPVLPPVLVPR is shared with SMAD3. npg 2. Peptide detectability. Only peptides spanning 7-25 amino acids and falling within a mass range of 700-3,000 Da were used. N-or C-terminal peptides that could be degraded or modified in the protein of interest were excluded. The sequences immediately flanking the N-and C-terminal peptides of the target sequence were also excluded from the evaluation (the sequence linking the SH-quant tag to the N terminus and the sequence linking the C-terminal peptide and the GST tag sequence).
3. Peptide digestibility. As the whole methodology is peptide centric and thus dependent on the completeness and specificity of the digestion step 46 , special care was taken to ensure that only end-product peptides would be selected for the assay. This was especially true for the SH-quant tag construction, which contains a KK dibasic sequence at its C-terminal part that could lead to miscleavages. The SH-quant tag configuration was retained, however, as systematic attempts to detect miscleavage products originating from the KK dibasic sequence using either accurate mass inclusion mass spectrometry or targeted SRM detection were negative (i.e., only the SH-quant tag end product was detected). For all the other peptides, only fully tryptic peptides with no miscleavages other than KP and RP were considered. N-or C-terminal dibasic residues (KK, KR, RK and RR) as well as surrounding acidic residues (Glu or Asp) in position P1 and P2 potentially leading to miscleavages were excluded.
4. Peptide stability. Peptide sequences containing oxidationsensitive residues, methionine only in this case, were excluded. However, these peptides, which usually ionize well, were kept as secondary choices in case no usable sequences would remain after the selection 47 . Peptides containing potential imide-forming residues (NG), potential deamidating residues (DP) or N-terminal glutamine (Q) were excluded as well.
Peptide selection. A first manual ranking of the proteotypic peptides was performed using peptide intensities extracted from the MS1 stage with the intention of selecting the best 'flyers' . This ranking was complemented by a manual evaluation of the tandem-MS spectral quality aimed at not excluding low-intensity MS1 peaks with intense selective fragment ions (TIC MS2 in Supplementary Data 2). Specifically, tandem-MS spectra presenting high-intensity singly charged y ions above the m/z of the parent ion were included in the second screen performed on the triple quadrupole instrument (TSQ Vantage, Thermo Fisher Scientific). In a preliminary SRM run, all selected peptides were targeted. The final best-responding candidates were selected by performing a pilot SRM analysis targeting the heavy-labeled versions of the peptides selected in the previous screen spiked in a nuclear extract digest prepared in the same way as for the real experiment. A minimum of two peptides per TF was finally selected for the multiplex analysis.
Nuclear extract sample preparation and spiking of in vitroexpressed heavy TF and SH-quant reference tags. Samples containing in vitro-expressed heavy TFs were run on separate gel lanes to allow for maximal protein recovery. Gel bands were excised and split into four fractions of equal size, one of which was promptly used, and the remaining ones were stored for future needs. Typically, expression levels of 3× to 4× were sufficient for four different multiplex assays. All in vitro-expressed heavy TFs were initially assessed for heavy-isotope incorporation levels during a targeted SRM run. If required, this initial step can be used for external heavy-TF quantitation using the SH-quant tag, hence providing estimates on (spike-in) loads for a multiplex assay. This external quantitation is also used for precise adjustment of the light and heavy SH-quant tag ratio, which in turn is fundamental for accurate quantitation using the multiplex approach. The quantities that needed to be spiked in in the case of TFs were determined by the necessity of achieving a good signal for the heavy-labeled SHquant tags in the nuclear matrix (multiplex). For nuclear extracts (NE), 400 µg (quantified using the BCA assay) of total NE protein (differentiation times: day 0 to day 6) were separated and fractionated by SDS-PAGE using 10% Tris-glycine gels. Gel bands were excised around the migration height of the proteins of interest: 50-60 kDa for RXRα and PPARγ, and 30-40 kDa and 45-70 kDa in the multiplexed analysis (thereby encompassing all ten TFs).
Gel fractions of NE and heavy TFs were subsequently pooled for reduction and alkylation followed trypsin digestion, as described above. The accurately quantified SH-quant tags (JPT Peptide Technologies) were added to each tube (200 fmol per tag) immediately after resuspension in the digestion buffer. Following trypsinization, peptides were extracted from gel fractions and accurately divided into aliquots of four equal volumes (technical replicates). Samples were then dried using a speed vacuum and stored at −20 °C before analysis.
Liquid chromatography-mass spectrometry (LC-MS/MS) analysis.
Dried aliquots (theoretical concentration, 100 µg) were resuspended in 20 µl LC-MS/MS loading solvent (2% acetonitrile, 0.1% formic acid), yielding a final theoretical concentration of nuclear extract of 5 µg/µl. Following resuspension, samples were allowed to settle for 1 h to increase overall peptide solubility before analysis. Typically, 5 µl of sample (theoretical total, 25 µg) was loaded and captured on a homemade capillary precolumn (C18; 3 µm, 200 Å; 2 cm × 250 µm) before analytical LC separation (nanoACQUITY UPLC, Waters). Samples were separated using a 90-min biphasic gradient starting from 100% solvent A (2% acetonitrile, 0.1% formic acid) to 90% solvent B (100% acetonitrile, 0.1% formic acid) on a Nikkyo (Nikkyo Technology) nanocolumn (C18; 3 µm, 100 Å; 15-cm length and 100-µm inner diameter; flow of 1 µl/min). The gradient was followed by a wash for 8 min at 90% solvent B and column re-equilibration for 12 min at 100% solvent A.
Selected reaction monitoring (SRM) of TFs. All samples were analyzed on a TSQ-Vantage triple quadrupole mass spectrometer (Thermo Fisher Scientific). A 0.7-FWHM-resolution window for both Q1 and Q3 was set for parent-and product-ion isolation. Fragmentation of parent ions was performed in Q2 at 1.5 mtorr, using collision energies calculated with the Pinpoint software (v1.1). Parent-ion selection was set for fully digested peptides on the doubly charged ion for both SH-quant tags and target proteins. Generally, singly charged peptide fragment ions ranging from y 3 to y n-1 were preferably monitored, unless otherwise stated. A complete list of all monitored transitions is provided in Supplementary Data 2. A parent-ion retention-time target window of 2 min to quantify RXRα or PPARγ and 5 min for the multiplexed quantification of ten TFs was set for Q1 during a scheduled SRM run. A total of respectively 88 and 76 transitions were monitored for RXRα and PPARγ in the single-protein quantification strategy, whereas a total of 492 transitions were typically monitored during a multiplex run. Cycle times of 0.5 s and 2 s were used for single npg and multiplexed SRM runs, respectively. A minimum dwell time of 10 ms or more was set for both single and multiplexed SRM assays. Samples were analyzed as three biological and three technical replicates (n = 3) in RXRα and PPARγ single-protein quantification assays. One biological replicate was analyzed in six technical replicates as a proof-of-concept of the multiplex SRM assay.
Evaluation of heavy-TF isotope incorporation and miscleavage during SRM. All in vitro-expressed heavy TFs were assessed for light-isotope (K and R) misincorporation before SRM quantification. The amounts of isotope misincorporation (usually ≤5%) were corrected in the final calculations of absolute endogenous concentrations. In addition, all SH-quant tags were monitored for trypsin miscleavage during a dedicated LC-MS run targeting the SH-quant tag and its potential miscleavage products to assess the extent of digestion completeness.
Data analysis and absolute quantification of TFs. Calculation of absolute levels of TFs was performed using a two-step procedure as outlined in Figure 1b . All data analyses were carried out using Pinpoint software (v.1.1). Peptide identification and peak-area integration of all SH-quant tags and targeted peptides as well as their transitions were manually verified in Pinpoint. Ten individual standard curves were established for all SH-quant tags using a concentration range of six values recorded in three technical replicates (Supplementary Fig. 14) . The performance-based definitions of lower limits of quantification (LLOQ) were applied as defined by the FDA 48 . Briefly, the threshold for the limit of detection (LOD) was set at 20% of the coefficient of variation (CV), whereas the LLOQ was set at 15% of the CV using three technical replicates for single and six technical replicates for multiplex quantification approaches. An example of the LLOQ found for an SH tag is provided in Supplementary Figure 16 . An analysis of variance (ANOVA) coupled with a Newman-Keuls post-hoc test was applied for calculating the differences in endogenous levels of TFs between different differentiation time points, where the level of P < 0.05 was considered as statistically significant. The calculation steps to derive absolute copy numbers per cell (nucleus) are presented in Supplementary Data 1.
SRM assay validation using accurately quantified proteins. Recombinant human α-synuclein (SYN, 15 N heavy isotope, MW: 14,625 Da) and histidyl-tRNA synthetase (HARS, MW: 59,849 Da, ProspecBio) were accurately quantified by UV spectrophotometry using their respective protein's molar extinction coefficient at 280 nm and by amino acid analysis (AAA). The AAA was performed twice on two dilutions of the original protein solution at the Functional Genomics Center, Zurich (FGCZ), and gave a precision of ±5%. Protein amounts corresponding to 5,000 (SYN = 3.64 ng, HARS = 14.3 ng) and 50,000 (SYN = 36.4 ng, HARS = 143 ng) copies were spiked into nuclear extract (D0, 400 µg) and analyzed by SDS-PAGE. SYN and HARS proteins were cut at their corresponding gel migration height as determined by reference proteins. In parallel, we retrieved the respective human ORFs (HARS, Thermo Fisher; SYN, in-house) and cloned them into our expression vector to enable the production of the respective heavy isotope-labeled proteins and thus to allow for a similar experimental workflow as the one used to quantify RXRα and PPARγ. Gel bands were pooled and digested with the heavy SH-tagged protein and the accurately quantified SH tags as outlined in the multiplex approach. SRM quantitation of spiked human (quantified by AAA) SYN and HARS peptides was achieved in a single SRM run using an 80-min LC gradient. A total of ten peptides were selected for HARS protein, of which seven peptides share sequence homology with the mouse HARS protein, two peptides are proteotypic for human and one peptide is proteotypic for mouse (endogenous) HARS. For SYN, two proteotypic peptides were monitored. Despite the high sequence homology between human and mouse SYN, endogenous levels of SYN could be accounted for by monitoring the ratio between the light (mouse endogenous) and the heavy 15 N-labeled peptides against the in vitro-expressed heavy SYN protein labeled at the terminal lysine. Samples were analyzed in three technical replicates.
Motif analysis. Regions enriched with H3K27ac as determined by Mikkelsen et al. 29 were scanned with FIMO 49 allowing for a P value of 10 −3 . Each match in those regions was then scored for log-likelihood given by the position weight matrix of the PPARγ motif from the JASPAR CORE database 50 , assuming uniform background.
PPARγ ChIP-seq data reanalysis. ChIP-seq data from Nielsen et al. 26 was processed as in Raghav et al. 31 .
Quantitative model of genome-wide TF DNA binding. The estimation of the PPARγ DNA binding profile is based on equilibrium thermodynamics and is described in detail in the Supplementary Note.
